Deracin 100 Meal
This treatment applies to the following species:Chlortetracycline
Type A Medicated Article
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Restricted Drug (California) - Use Only as Directed.
Keep out of reach of children.
Not For Human Use.
Active Drug Ingredients:
Chlortetracycline as Chlortetracycline Calcium Complex equivalent to 100 grams Chlortetracycline Hydrochloride / lb.
Ingredients:
Dried Streptomyces aureofaciens fermentation product in a carrier suitable for incorporation in feed.
For Use in the Manufacture of Medicated Animal Feeds.
CAUTION: For use in Dry Feeds ONLY. NOT FOR USE IN LIQUID MEDICATED FEEDS.
Use directions:
Mix sufficient Deracin™ 100 Meal Type A Medicated Article to supply desired concentration of chlortetracycline per ton with part of the feed ingredients to make a preblend. Add the remainder of the ingredients and mix thoroughly. For specific use levels, see Indications for Use.
Mixing directions:
Level desired grams per ton |
Amount of medicated article per ton* |
50 |
1/2 lb |
100 |
1 lb |
200 |
2 lb |
400 |
4 lb |
500 |
5 lb |
* It is recommended that 1 pound of Deracin™ 100 Meal Type A Medicated Article be diluted with 3 pounds of one of the feed ingredients to form a 4 pound working premix. Use 2 pounds of the working premix to make a preblend (see Use Directions) for a Type C feed containing 50 g chlortetracycline / ton of feed.
Indications For Use |
Chlortetracycline mg per lb body weight per day |
Cattle |
|
Beef Cattle (over 700 lb): control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. |
0.5 |
Beef and Non-Lactating Dairy Cattle: As an aid in control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. For use in free-choice feeds. A medicated feed mill license is required when the free-choice feed is manufactured using a proprietary formula and/or specifications. Free-choice feed formulations must be FDA approved. |
0.5-2.0 |
Calves, Beef, and Non-Lactating Dairy Cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. Feed for not more than 5 days. The appropriate amount of Deracin™ containing feed supplement may be mixed in the cattle’s daily ration or administered as a top dress. If the Deracin™ containing feed supplement is administered as a top dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time. |
10 |
Swine |
|
Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: This drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight). Feed for not more than 14 days. |
10 |
Turkeys |
|
Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline. Feed continuously for 7 to 14 days. |
25 |
Indications For Use |
mg per head per day |
Cattle |
|
Growing Cattle (over 400 lb): For the reduction of the incidence of liver abscesses. |
70 |
Beef Cattle and Dairy Replacement Heifers: Control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. |
350 |
Beef Cattle (under 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. |
350 |
Sheep |
|
Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline. |
80 |
Indications For Use |
In complete feed |
Swine |
|
Reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline. |
50-100 |
Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. Feed continuously for not more than 14 days. |
400 |
Ducks |
|
Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline. Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending upon age and severity of disease. Feed for not more than 21 days |
200-400 |
Chickens |
|
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. Feed continuously for 7 to 14 days. |
100-200 |
Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline. Feed continuously for 7 to 14 days. |
200-400 |
Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline. Feed for 5 days. |
500 |
Turkeys |
|
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. Feed continuously for 7 to 14 days. |
200 |
Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline. Feed continuously for 7 to 14 days. |
400 |
Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline. |
400 |
Withdrawal Periods And Residue WarningsNo withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Do not feed to ducks or turkeys producing eggs for human consumption. |
Store below 25°C (77°F), excursions permitted to 40°C (104°F). Tightly reseal opened bags.
Approved by FDA under ANADA # 200-510
Deracin is a trademark of Pharmgate Inc.
Marketed by:
Pharmgate Animal Health, LLC, 14040 Industrial Road, Omaha, Nebraska 68144
Net wt. |
|
50 LB (22.68 Kg) |
Rev. 09-23 Bag D100 |
CPN: 1635029.2
14040 INDUSTRIAL ROAD, OMAHA, NE, 68144
Toll-Free: | 800-380-6099 | |
Fax: | 910-679-8368 | |
Website: | www.pharmgate.com | |
General Inquires: | info@pharmgate.com | |
Support: | customerservice@pharmgate.com |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details. |
Copyright © 2024 Animalytix LLC. Updated: 2024-11-27